An International Real-World Analysis of the Efficacy and Safety of Lorlatinib Through Early or Expanded Access Programs in Patients With Tyrosine Kinase Inhibitor–Refractory ALK-Po...

by Viola W. Zhu, Yen Ting Lin, Dong Wan Kim, Herbert H. Loong, Misako Nagasaka, Hao To, Yvonne Li En Ang, Chan Young Ock, Nishan Tchekmedyian, Sai Hong Ignatius Ou, Nicholas L. Syn, Thanyanan Reungwetwattana, Chia Chi Lin, Ross A. Soo
Published 2020